- Home
- WPP vs MEDP Comparison
WPP vs MEDP Comparison
Compare WPP & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WPP
- MEDP
- Stock Information
- Founded
- WPP 1985
- MEDP 1992
- Country
- WPP United Kingdom
- MEDP United States
- Employees
- WPP N/A
- MEDP N/A
- Industry
- WPP Advertising
- MEDP Biotechnology: Commercial Physical & Biological Resarch
- Sector
- WPP Consumer Discretionary
- MEDP Health Care
- Exchange
- WPP Nasdaq
- MEDP Nasdaq
- Market Cap
- WPP 7.7B
- MEDP 8.5B
- IPO Year
- WPP N/A
- MEDP 2016
- Fundamental
- Price
- WPP $28.20
- MEDP $323.50
- Analyst Decision
- WPP Sell
- MEDP Hold
- Analyst Count
- WPP 1
- MEDP 11
- Target Price
- WPP N/A
- MEDP $338.90
- AVG Volume (30 Days)
- WPP 523.0K
- MEDP 425.9K
- Earning Date
- WPP 08-06-2025
- MEDP 07-21-2025
- Dividend Yield
- WPP 9.32%
- MEDP N/A
- EPS Growth
- WPP 389.11
- MEDP 33.36
- EPS
- WPP 0.62
- MEDP 13.09
- Revenue
- WPP $18,454,623,978.00
- MEDP $2,156,580,000.00
- Revenue This Year
- WPP N/A
- MEDP $5.69
- Revenue Next Year
- WPP $1.46
- MEDP $3.36
- P/E Ratio
- WPP $8.98
- MEDP $24.71
- Revenue Growth
- WPP N/A
- MEDP 9.87
- 52 Week Low
- WPP $27.98
- MEDP $250.05
- 52 Week High
- WPP $57.37
- MEDP $459.77
- Technical
- Relative Strength Index (RSI)
- WPP 21.91
- MEDP 58.67
- Support Level
- WPP $29.12
- MEDP $316.66
- Resistance Level
- WPP $35.95
- MEDP $334.33
- Average True Range (ATR)
- WPP 0.60
- MEDP 8.75
- MACD
- WPP -0.66
- MEDP 1.07
- Stochastic Oscillator
- WPP 2.91
- MEDP 62.19
About WPP WPP plc
Headquartered in the United Kingdom, WPP is one of the world's largest ad holding companies based on annual revenue. Its services, which include traditional and digital advertising, public relations, and consulting, are provided worldwide, with over 70% of its revenue coming from more developed regions such as North America, the UK, and Western Europe.
About MEDP Medpace Holdings Inc.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the US, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.